Thomas Balzer
Vermogen: - $ op 31-08-2026
Vermogen: - $ op 31-08-2026
Thomas Balzer is currently Chief Medical Officer & SVP-Clinical Development at Lakewood-Amedex Biotherapeutics, Inc. since 2023.
Formerly, Dr. Balzer was Vice President at Bayer U.S.
LLC.
Education includes a doctorate from Freie Universität Berlin.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-07-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| LAKEWOOD-AMEDEX BIOTHERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Bayer U.S. LLC
Bayer U.S. LLC Information Technology ServicesTechnology Services Provides information technology services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amedex Therapeutics, Inc.
Amedex Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel antimicrobial therapeutics | Health Technology |
Bayer U.S. LLC
Bayer U.S. LLC Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau